Evaluating candidate autoantigens in rheumatoid arthritis.
Cope
A P
AP
Kennedy Institute of Rheumatology, Hammersmith, London, UK.
Sønderstrup
G
G
D000483:Alleles; D000818:Animals; D001172:Arthritis, Rheumatoid / Q000235:genetics / Q000276:immunology* / Q000628:therapy; D001323:Autoantibodies / Q000097:blood; D001324:Autoantigens / Q000276:immunology*; D001327:Autoimmune Diseases / Q000235:genetics / Q000276:immunology* / Q000628:therapy; D015704:CD4 Antigens / Q000276:immunology; D002356:Cartilage / Q000276:immunology; D004195:Disease Models, Animal; D018604:Epitope Mapping; D018984:Epitopes, T-Lymphocyte / Q000276:immunology; D020022:Genetic Predisposition to Disease; D015804:HLA-DR4 Antigen / Q000235:genetics / Q000276:immunology; D006801:Humans; D006825:Hybridomas / Q000276:immunology; D051379:Mice; D008822:Mice, Transgenic; D010007:Osteochondritis / Q000276:immunology
D001323:Autoantibodies; D001324:Autoantigens; D015704:CD4 Antigens; D018984:Epitopes, T-Lymphocyte; D015804:HLA-DR4 Antigen